HomeIMUX • NASDAQ
Immunic Inc
add
$0.84
1.24%
After Hours:(1.19%)-0.0100
$0.83
Closed: Sep 18, 5:35:09 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.08M | 18.71% |
Net income | -26.82M | -25.44% |
Net profit margin | — | — |
Earnings per share | -0.20 | 4.76% |
EBITDA | -27.04M | -18.68% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.31M | -30.60% |
Total assets | 61.43M | -28.98% |
Total liabilities | 27.52M | 20.07% |
Total equity | 33.91M | — |
Shares outstanding | 98.65M | — |
Price to book | 2.44 | — |
Return on assets | -165.25% | — |
Return on capital | -442.85% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.82M | -25.44% |
Cash from operations | -24.61M | -44.43% |
Cash from investing | -36.00K | 80.00% |
Cash from financing | 65.52M | — |
Net change in cash | 41.01M | 332.80% |
Free cash flow | -13.17M | -31.85% |
Previous close
$0.83
Day range
$0.82 - $0.85
Year range
$0.56 - $2.11
Market cap
82.84M USD
Avg Volume
1.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
May 2003
Website
Employees
90
